64 DAFTAR PUSTAKA
Al Qur’an dan Terjemahannya. (2008) Jakarta: Departemen Agama Republik Indonesia.
Al-Fattah, Abd., Ghuddah, Abu. (2005) 40 Strategi Pembelajaran Rasulullah.
Sumedi dan R. Umi Baroroh (penj.). Yogyakarta: Tiara Wacana Yogya.
Al-Jauziyah. (2008) Ath-thibbun Nabawi, Pengobatan Cara Nabi Muhammad saw. Surabaya: Arkola.
American Diabetes Association (ADA). (2010) Diagnosis and Classification of Diabetes Mellitus Diabetes Care. USA.
American Diabetes Association (ADA). (2012) Standards of Medical Care in Diabetes 2012. American Diabetes Assosiation. United States of America dalam situs www.care.diabetesjournals.org diakses tanggal 8 April 2018.
Baihaqi, A. K. (2001) Mendidik Anak Dalam Kandungan. Jakarta: Darul Ulum; hal 101.
Bakri, Oemar. (1972) Tafsir Rahmad. Jakarta: Mutiara.
Baur, JA., Pearson, KJ., Price NL., et al. (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature;444: pp.337-342.
Bellentani, S., Scaglioni, F., Marino, M., Bedogni, G. (2010) Epidemiology og non-alcoholic fatty liver disease. Dig Dis;28: pp.155-161.
Bensellam, M., Laybutt, D.R., Jonas, J.C. (2012) The molecular mechanisms of pancreatic ß-cell glucotoxicity : recent findings and future research directions, Mol. Cell. Endocrinol. 364; pp.1-27.
Bishayee, A. (2009) Cancer and Prevention and Treatment with Resveratrol:
From Rodent Studies to Clinical Trials. Cancer Prev Res 2 (5) : pp.409-418.
Bjornholm, M., Zierath, J.R. (2005) Insulin signal transduction in human skeletal muscle: identifying the defect in type II diabetes. Biochem.
Soc. Trans. 33; pp.354-357.
Bloomgarden, Z.T. (2004) Diabetes complications. Diabetes Care 27:
pp.1506-1514.
65 Bujanda, L., Hijona, E., Larzabel, M., et al. (2008) Resveratrol inhibits
nonalcoholic fatty liver disease in rats. BMC Gastroenterol.
Burns, J., Yokota, T., Ashihara, H., et.al. (2002) Plant foods and herbal sources of resveratrol. Jour. Agric.Food Chem. pp.3337-3340.
Cameron, AJ., Welborn, TA., Zimmet, DZ., Dunotan, DW., Owen, N., Salmon, J. (2003) Overweight and obesity in Australia: The 1999- 2000 Australian diabetes, obesity and life style study (AusDiab). The Medical Journal of Australia (MJA); 175: pp.472-432.
Chen, S., Li, J., Zhang, Z., Li, W., Sun, Y., Zhang, Q., Feng, X., Zhu, W.
(2012) Effects of resveratrol on the amelioration of insulin resistance in KKAy mice, Can .J. Physiol. Pharmacol. 90; pp.237-242.
Cheng, A.Y & Fantus, I.G. (2005) Oral antihyperglikemic therapy for type 2 diabetes mellitus. CMAJ 172: pp.213-226.
Cui, X., Jin, Y., Hofseth, AB., et al. (2010) Resveratrol suppresses colitis and colon cancer associated with colitis. Cancer Prev Res (Phila PA);3:
pp.549-559.
Culpitt, SV., Rogers, DF., Fenwick, PS., et al. (2003) Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD. Thorax;58: pp.942-946.
Departemen Agama RI. (2003) Petunjuk Teknis Pedoman Sistem Produksi Halal. Jakarta: Bagian Proyek Sarana dan Prasarana Produk Halal Direktorat Jenderal Bimbingan Masyarakat Islam dan Penyelenggaraan Haji; Hal: 3.
Departemen Kesehatan. (2005) Pharmaceutical Care untuk Penyakit Diabetes Melitus.
Donnelly, LE., Newton, R., Kennedy, GE., et al. (2004) Anti-inflammatory effects of resveratrol in lung epithelial cells:molecular mechanisms.
Am J Physiol Lung Cell Mol Physiol;287: pp.774-783
Effendy, Mochtar. (2001) Ensiklopedi Agama dan Filsafat. Jakarta:
Universitas Sriwijaya.
Ferrero, ME., Bertelli, AE., Fulgenzi, A., et al. (1998) Activity in vitro of resveratrol on granulocyte and monocyte adhesion to endothelium, Am J Clin Nutr;68: pp.1208-1214.
Gomez, Zorita S., Quintela, A. Fernandez., Lasa, A., Hijona, E., Bujanda, L., Portillo, M.P. (2013) Effects of resveratrol on obesity-related
66 inflamation markers in adipose tissue of genetically obese rats, Nutrition.
Hashman, Ade. (2012) Rahasia Kesehatan Rasulullah. Jakarta: Noura Book.
Imani, A. K. F. (2005) Tafsir Nurul Qur’an. Jakarta: Penerbit Al-Huda.
Ja’far, Abu Muhammad bin Jabir Ath-Thabari. (2009) Tafsir Ath-Thabari.
Jakarta: Pustaka Azzam.
Kang, L., Heng, W., Yuan, A., Baolin, L., Fang, H. (2010) Resveratrol modulates adipokine expression and improves insulin sensitivity in adipocytes: relative to inhibition of inflammatory responses.
Biochimie.92: pp.789-796.
Kemenkes Ri. (2013) Riset Kesehatan Dasar; RISKESDAS. Jakarta:
Balitbang Kemenkes Ri.
Kumar, A., Sharma, SS. (2010) NF-kappaB inhibitory action of resveratrol : a probable mechanism of neuroprotection in experimental diabetic neuropathy. Biochem Biophys Res Commun;394: pp.360-365.
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliot, P., et al.
(2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1 alpha. Cell.
127: pp.1109-1122.
Lee, Y.E., Kim, J.W., Lee, E.M., Ahn, Y.B., Song, K.H., Yoon, K.H., Kim, H.W., Park, C.W., Li, G., Liu, Z., Ko, S.H. (2012) Chronic resveratrol treatment protects pancreatic islets against oxidative stress in db/db mice, PloS ONE 7; e50412.
Lenzen, S. (2008) Oxidative stress : the vulnerable beta-cell, Biochem. Soc.
Trans. 36; pp.343-347.
Li, Y., Backesjo, CM., Haldosen, LA., Lindgren, U. (2009) Resveratrol inhibits proliferation and promotes apoptosis of osteosarcoma cells.
Eur J Pharmacol;609: pp.13-18.
Liu, K., Zhou, R., Wang, B., Mi, M.T. (2014) Effetcs of resveratrol on glucose control and insulin sensitivity : a meta-analysis of 11 randomized controlled trials. The American Journal of Clinical Nutrition: pp.1514- 1515.
67 Marambaud, Philippe., et al. (2005) Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides. Journal of Biological Chemistry. 280(45).
Massiello, P. (2006) Animal models of type 2 diabetes with reduced pancreatic beta-cell mass, Int. J. Biochem. Cell. Biol. 38; pp.873-893.
Movahed, A., Nabipour, I., Louis, Lieben X., Thandapilly, S.J., Yu, L., Kalantarhormozi, M., Rekabpour, S.J., Netticadan, T. (2013) Antihyperglicemic effects of short term resveratrol supplementation in type 2 diabetic patients. Evid. Based Complement. Alternat. Med.
Mustafa, Al-Maraghi Ahmad. (1987) Terjemah Tafsir AlMaraghi juz 6.
Semarang: CV. Toha Putra.
Novelle, M.G., et al. (2015) Resveratrol supplementation: Where are we now and where should we go? Ageing Research Reviews.
Orimo, M., Minamino, T., Miyauchi, H., et al. (2009) Protective role of SIRT1 in diabetic vascular dysfunction. Arterioscleral Thromb Vasc Biol;29:
pp.889-894.
Palermo,A., Maggi, D., Maurizi, A.R., Pozzilli, P., Buzzetti, R. Prevention of type 2 diabetes mellitus: is it feasible? Diabetes Metab. Res. Rev. 30, pp.4-12.
Palsamy, P & Subramanian, S. (2008) Resveratrol, a natural phytoalexin, normalizes hyperglicemia in streptozotocin-nicotinamide induced experimental diabetic rats. Biomed. Pharmacother. 62: pp.598-605.
Pedersen, S.D. (2013) Metabolik complications of obesity, Best Pract. Res.
Clin. Endocrinol. Metab. 27; pp.179-193.
Perkumpulan Endokrinologi Indonesia. (2015) Petunjuk Praktis: Terapi Insulin Pada Pasien Diabetes Melitus, PB. Jakarta : PERKENI.
RIKERDAS (Riset Kesehatan Dasar). (2007) Jakarta : Badan Penelitian dan Pengembangan Kesehatan.
Ruderman, N.B., Carling, D., Prentki, M., Cacicedo, J.M., AMPK. (2013) Insulin resistance, and the metabolic syndrome, J. Clin. Invest. 123;
pp.2764-2772.
Schlacterman, A., Valle, F., Wall, KM., et al. (2008) Combined resveratrol, quercetin and cathecin treatment reduces breast tumor growth in a nude mouse model. Transl Oncol;1: pp.19-27.
68 Sharma, S., Anjaneyulu, M., Kulkarni, SK., Chopra, K. (2006) Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats.
Pharmacology;76: pp.69-75
Stroker, H. Stephen. (2014) Organic and Biological Chemistry, Seventh Edition. USA: Cengange Learning; pp.112.
Su, HC., Hung, LM., Chen, JK. (2006) Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin induced diabetic rats.
Am J Physiol Endocrinol Metab;290:pp.1339-1346.
Sudoyo, A.W., Alwi, I., Setiyohadi, B. (2006) Buku Ajar Ilmu Penyakit Dalam. Ed V Jilid III. Jakarta : Interna Publishing. 1709-1713.
Tan, Z., Zhoue, L.J., Mu, P.W., Liu, S.P., Chen, S.J., Fu, X.D., Wang, T.H.
(2012) Caveolin-3 is involved in the protection of resveratrol against high-fat-diet-induced-insulin resistance by promoting GLUT4 translocation to the plasma membrane in skeletal muscle of ovariectomized rats, J. Nutr. Biochem. 23;pp.1716-1724.
Taufik, Ahmad. (2010) Pendidikan Agama Islam. Surakarta : Yuma Pustaka.
Trela, B.C., and Waterhouse, A.L. (1996) “Resveratrol:isomericmolar absorptivities and stability,” Journal of Agricultural and Food Chemistry. vol.44(5), pp.1253–1257.
Um, J.H., Park, S.J., Kang, H., Yang, S., Foretz, M., Mcburney, M.W., Kim, M.K., Viollet, B., Chung, J.H. (2010) AMP-activated protein kinase- deficient mice are resistant to the metabolic effects of resveratrol, Diabetes 59; pp.554-563.
Wallerath, T., Li, H., Godtel-Ambrust, U., et al. (2005) A blend of polyphenolic compounds explains the stimulatory effect of red wine on human endothelial NO synthase. Nitric Oxide.
Wang, Z., Huang, Y., Zou, J., et al. (2002) Effects of red wine polyphenol resveratrol on platelet aggregation in vivo and in vitro, In J Mol Med;9:pp.77-79.
Weir, G.C., Bonner-Weir, S. (2013) Islet ß cell mass in diabetes and how it relates to function, birth and death, Ann.N.Y. Acad. Sci. 1281; pp.92- 105.
You, M., Liang, X., Ajmo, JM., Ness, GC. (2008) Involvement of mammalian sirtuin 1 in the action of ethanol in the liver. Am J Physiol Gastrointest Liver Physiol;294:pp.G892-G898.
69 Zhang, J., Chen, L., Zheng, J., Zeng, T., Li, H., Xiao, H., Deng, X., Hu, X.
(2012) The protective effects of resveratrol on islets insulin secreation and morphology in mice on a high-fat diet, Diabetes Res. Clin. Pract.
97; pp.474-482.
Zhu, W., Chen, S., Li, Z., Zhao, X., Li, W., Sun, Y., Zhang, Z., Ling, W., Feng, X. (2014) Effects and mechanism of resveratrol on the amelioration of oxidative stress and hepatic steatosis in KKAy mice, Nutr. Metab. (Lond).
Zuhroni, Riani, N., Nasruddin, N. (2003) Islam untuk Disiplin Ilmu Kesehatan dan Kedokteran 2. Jakarta : DEPAG RI.
Zuhroni. (2010) Pandangan islam terhadap Masalah Kedokteran dan Kesehatan. Jakarta: Universitas Yarsi.